SCHEMBL14782820

SCHEMBL14782820

COC(=O)c1cc(CNC(=O)C2CCOC2)ccc1Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.48
HPGD P15428 2/20 0.48
TSHR P16473 3/20 0.46
EPHX2 P34913 1/20 0.43
ALDH1A1 P00352 4/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
P2RX7 Q99572 2/20 0.42
ERCC1 P07992 1/20 0.40
ERCC4 Q92889 1/20 0.40
POLB P06746 1/20 0.40
GAA P10253 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
NPC1 O15118 1/20 0.40
PKM P14618 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
CCR2 P41597 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14782692 0.87 ALDH1A1 (0.45) LMNAHPGDTSHREPHX2ALDH1A1
SCHEMBL14782977 0.87 HPGD (0.55) LMNAHPGDTSHREPHX2ALDH1A1
SCHEMBL14782827 0.85 ERCC1 (0.53) LMNAHPGDTSHREPHX2ALDH1A1
Hydrochloric Acid SCHEMBL25251752 0.81 HPGD (0.49) LMNAHPGDTSHREPHX2ALDH1A1
SCHEMBL14782775 0.80 PKM (0.55) LMNAHPGDTSHRALDH1A1SMN1; SMN2
SCHEMBL8278937 0.74 MAPT (0.50) LMNAHPGDALDH1A1POLBNPC1
SCHEMBL14979286 0.74 HPGD (0.44) LMNAHPGDTSHRALDH1A1SMN1; SMN2
SCHEMBL14782772 0.73 ERCC1 (0.52) LMNAHPGDEPHX2ALDH1A1SMN1; SMN2
SCHEMBL30491752 0.73 ERCC1 (0.52) LMNAHPGDEPHX2ALDH1A1SMN1; SMN2
SCHEMBL14783152 0.72 LMNA (0.55) LMNAHPGDTSHRALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013038308-A1 SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS AS mPGES-1 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2013-03-21 WO disclosed